Slow responses to standard dose rituximab in immune thrombocytopenic purpura

av Kelly, Kevin, Gleeson, Mary, Murphy, Philip Thomas
Publicerad 2009

Cost (Non)-Recovery by Platform Technology Facilities in the Bio21 Cluster

av Gibbs, Gerard, Clark, Stella, Quinn, JulieAnne, Gleeson, Mary Joy
Publicerad 2010

Comparison of the diagnostic performance and impact on management of 18F-FDG PET/CT and whole-body MRI in multiple myeloma

av Westerland, Olwen, Amlani, Ashik, Kelly-Morland, Christian, Fraczek, Michal, Bailey, Katherine, Gleeson, Mary, El-Najjar, Inas, Streetly, Matthew, Bassett, Paul, Cook, Gary J. R., Goh, Vicky
I publikationen Eur J Nucl Med Mol Imaging (2021)

CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial

av Gleeson, Mary, Peckitt, Clare, To, Ye Mong, Edwards, Laurice, Oates, Jacqueline, Wotherspoon, Andrew, Attygalle, Ayoma D, Zerizer, Imene, Sharma, Bhupinder, Chua, Sue, Begum, Ruwaida, Chau, Ian, Johnson, Peter, Ardeshna, Kirit M, Hawkes, Eliza A, Macheta, Marian P, Collins, Graham P, Radford, John, Forbes, Adam, Hart, Alistair, Montoto, Silvia, McKay, Pamela, Benstead, Kim, Morley, Nicholas, Kalakonda, Nagesh, Hasan, Yasmin, Turner, Deborah, Cunningham, David
I publikationen Lancet Haematol (2018)

Factors Affecting COVID-19 Outcomes in Cancer Patients: A First Report From Guy's Cancer Center in London

av Russell, Beth, Moss, Charlotte, Papa, Sophie, Irshad, Sheeba, Ross, Paul, Spicer, James, Kordasti, Shahram, Crawley, Danielle, Wylie, Harriet, Cahill, Fidelma, Haire, Anna, Zaki, Kamarul, Rahman, Fareen, Sita-Lumsden, Ailsa, Josephs, Debra, Enting, Deborah, Lei, Mary, Ghosh, Sharmistha, Harrison, Claire, Swampillai, Angela, Sawyer, Elinor, D'Souza, Andrea, Gomberg, Simon, Fields, Paul, Wrench, David, Raj, Kavita, Gleeson, Mary, Bailey, Kate, Dillon, Richard, Streetly, Matthew, Rigg, Anne, Sullivan, Richard, Dolly, Saoirse, Van Hemelrijck, Mieke
I publikationen Front Oncol (2020)